pegylated interferon alpha 2a + ribavirin

DRUG2 trials

Sponsors

Tehran Hepatitis Center, Federico II University

Conditions

Chronic Hepatitis CHepatitis C

Phase 3

Effectiveness and Side Effects of Pegylated Interferon Alpha-2a (Pegaferon®) Plus Ribavirin in the Patients With Chronic Hepatitis C

CompletedNCT00527540

Tehran Hepatitis CenterHepatitis C

Start: 2007-02-28End: 2008-12-31Target: 60Updated: 2009-01-21

24 VS 48-WEEK TREATMENT WITH PEG-IFN ALPHA-2A IN PATIENTS WITH GENOTYPE 2/3 CHRONIC HEPATITIS C

WithdrawnNCT01517308

Federico II UniversityChronic Hepatitis C

Start: 2012-05-31End: 2015-11-30Updated: 2012-03-19